At a glance
ClinicalIndex Comparison RecordN/ACompleted· 149 enrolled
Drug / intervention
iNCDSS based insulin regime +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Study to Assess the Efficacy and Safety of iNCDSS Assisted Insulin Dosage Titration System on Glucose Control in Type 2 Diabetes Mellitus Patients : a Muticenter, Single-blind, Randomized Controlled Study
In Brief
A clinical study evaluating iNCDSS based insulin regime and routine insulin treatment regime for Type 2 Diabetes. Completed, enrolled 149 participants across 1 site.
Detailed Summary
This is a multi-center, single-blind, parallel group, randomized controlled trial to access the effect and safety of the Artificial Intelligence Assisted Insulin Titration System (iNCDSS) in patients with Type 2 Diabetes Mellitus.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 2 Diabetes
CountriesChina
CollaboratorsFudan University, Xuhui Central Hospital, Shanghai
Timeline
N/ACompletedFinished
202120222023202420252026
First PostedNov 2020
Enrollment StartOct 2021
Primary CompletionSep 2022
TodayJul 2026
First PostedNov 24, 2020
Enrollment StartOct 1, 2021
Primary CompletionSep 8, 2022
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 5.6 years ago
Interventions
iNCDSS based insulin regimedrug
Patients of this group will receive the insulin regime set by the AI assisted insulin titration system (iNCDSS).
routine insulin treatment regimedrug
Patients of this group will receive the insulin regime recommended by professional endocrinologists.